17-45844952-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_175882.3(SPPL2C):āc.46A>Cā(p.Ile16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_175882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPPL2C | NM_175882.3 | c.46A>C | p.Ile16Leu | missense_variant | 1/1 | ENST00000329196.7 | NP_787078.2 | |
MAPT-AS1 | NR_024559.1 | n.35-791T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPPL2C | ENST00000329196.7 | c.46A>C | p.Ile16Leu | missense_variant | 1/1 | NM_175882.3 | ENSP00000332488 | P1 | ||
MAPT-AS1 | ENST00000634876.2 | n.183-791T>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249692Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134984
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461622Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 727084
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.46A>C (p.I16L) alteration is located in exon 1 (coding exon 1) of the SPPL2C gene. This alteration results from a A to C substitution at nucleotide position 46, causing the isoleucine (I) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at